These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 24944744)

  • 1. Synthesis, Characterization, and in Vitro Evaluation of a New TSPO-Selective Bifunctional Chelate Ligand.
    Denora N; Margiotta N; Laquintana V; Lopedota A; Cutrignelli A; Losacco M; Franco M; Natile G
    ACS Med Chem Lett; 2014 Jun; 5(6):685-9. PubMed ID: 24944744
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis, characterization, and in vitro evaluation of new coordination complexes of platinum(II) and rhenium(I) with a ligand targeting the translocator protein (TSPO).
    Margiotta N; Denora N; Piccinonna S; Laquintana V; Lasorsa FM; Franco M; Natile G
    Dalton Trans; 2014 Nov; 43(43):16252-64. PubMed ID: 25069996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Evaluation of a Novel
    Liu P; Wang T; Yang R; Dong W; Wang Q; Guo Z; Ma C; Wang W; Li H; Su X
    ACS Omega; 2020 Dec; 5(49):31657-31664. PubMed ID: 33344817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [
    Kumari N; Kaul A; Deepika ; Srivastava K; Mishra G; Bhagat S; Singh VK; KumarTiwari A
    Bioorg Chem; 2022 Apr; 121():105678. PubMed ID: 35176557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro targeting and imaging the translocator protein TSPO 18-kDa through G(4)-PAMAM-FITC labeled dendrimer.
    Denora N; Laquintana V; Lopalco A; Iacobazzi RM; Lopedota A; Cutrignelli A; Iacobellis G; Annese C; Cascione M; Leporatti S; Franco M
    J Control Release; 2013 Dec; 172(3):1111-25. PubMed ID: 24096015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Characterization, and Cytotoxicity of the First Oxaliplatin Pt(IV) Derivative Having a TSPO Ligand in the Axial Position.
    Savino S; Denora N; Iacobazzi RM; Porcelli L; Azzariti A; Natile G; Margiotta N
    Int J Mol Sci; 2016 Jun; 17(7):. PubMed ID: 27347942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Evaluation of Tricarbonyl (99m)Tc-Labeled 2-(4-Chloro)phenyl-imidazo[1,2-a]pyridine Analogs as Novel SPECT Imaging Radiotracer for TSPO-Rich Cancer.
    Choi JY; Iacobazzi RM; Perrone M; Margiotta N; Cutrignelli A; Jung JH; Park do D; Moon BS; Denora N; Kim SE; Lee BC
    Int J Mol Sci; 2016 Jul; 17(7):. PubMed ID: 27399688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delivery of Proapoptotic Agents in Glioma Cell Lines by TSPO Ligand-Dextran Nanogels.
    Lopalco A; Cutrignelli A; Denora N; Perrone M; Iacobazzi RM; Fanizza E; Lopedota A; Depalo N; de Candia M; Franco M; Laquintana V
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29641449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translocator protein ligand-PLGA conjugated nanoparticles for 5-fluorouracil delivery to glioma cancer cells.
    Laquintana V; Denora N; Lopalco A; Lopedota A; Cutrignelli A; Lasorsa FM; Agostino G; Franco M
    Mol Pharm; 2014 Mar; 11(3):859-71. PubMed ID: 24410438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TSPO Ligand-Methotrexate Prodrug Conjugates: Design, Synthesis, and Biological Evaluation.
    Laquintana V; Denora N; Cutrignelli A; Perrone M; Iacobazzi RM; Annese C; Lopalco A; Lopedota AA; Franco M
    Int J Mol Sci; 2016 Jun; 17(6):. PubMed ID: 27322261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Highly selective luminescent nanostructures for mitochondrial imaging and targeting.
    Fanizza E; Iacobazzi RM; Laquintana V; Valente G; Caliandro G; Striccoli M; Agostiano A; Cutrignelli A; Lopedota A; Curri ML; Franco M; Depalo N; Denora N
    Nanoscale; 2016 Feb; 8(6):3350-61. PubMed ID: 26763470
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural requirements to obtain highly potent and selective 18 kDa Translocator Protein (TSPO) Ligands.
    Taliani S; Pugliesi I; Da Settimo F
    Curr Top Med Chem; 2011; 11(7):860-86. PubMed ID: 21291396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of N-benzyl-N-[11C]methyl-2- (7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide ([11C]DAC) as a novel translocator protein (18 kDa) radioligand in kainic acid-lesioned rat.
    Yanamoto K; Yamasaki T; Kumata K; Yui J; Odawara C; Kawamura K; Hatori A; Inoue O; Yamaguchi M; Suzuki K; Zhang MR
    Synapse; 2009 Nov; 63(11):961-71. PubMed ID: 19593823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An Updated View of Translocator Protein (TSPO).
    Denora N; Natile G
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repeated administration of AC-5216, a ligand for the 18 kDa translocator protein, improves behavioral deficits in a mouse model of post-traumatic stress disorder.
    Qiu ZK; Zhang LM; Zhao N; Chen HX; Zhang YZ; Liu YQ; Mi TY; Zhou WW; Li Y; Yang RF; Xu JP; Li YF
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Aug; 45():40-6. PubMed ID: 23624119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antidepressant-like and anxiolytic-like effects of YL-IPA08, a potent ligand for the translocator protein (18 kDa).
    Zhang LM; Zhao N; Guo WZ; Jin ZL; Qiu ZK; Chen HX; Xue R; Zhang YZ; Yang RF; Li YF
    Neuropharmacology; 2014 Jun; 81():116-25. PubMed ID: 24067925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent developments on PET radiotracers for TSPO and their applications in neuroimaging.
    Zhang L; Hu K; Shao T; Hou L; Zhang S; Ye W; Josephson L; Meyer JH; Zhang MR; Vasdev N; Wang J; Xu H; Wang L; Liang SH
    Acta Pharm Sin B; 2021 Feb; 11(2):373-393. PubMed ID: 33643818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Subcellular distribution of the 18kDa translocator protein and transcript variant PBR-S in human cells.
    Liu GJ; Middleton RJ; Banati RB
    Gene; 2017 May; 613():45-56. PubMed ID: 28263860
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and Characterization of a "Clickable" PBR28 TSPO-Selective Ligand Derivative Suitable for the Functionalization of Biodegradable Polymer Nanoparticles.
    Auriemma R; Sponchioni M; Capasso Palmiero U; Rossino G; Rossetti A; Marsala A; Collina S; Sacchetti A; Moscatelli D; Peviani M
    Nanomaterials (Basel); 2021 Jun; 11(7):. PubMed ID: 34203263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of N-methyl-(2-arylquinolin-4-yl)oxypropanamides as leads to PET radioligands for translocator protein (18 kDa).
    Brouwer C; Jenko K; Zoghbi SS; Innis RB; Pike VW
    J Med Chem; 2014 Jul; 57(14):6240-51. PubMed ID: 24949670
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.